$FRDBullishMed

Friedman Q4 Profit Rises Due To High Sales Volume; Issues Q1 FY27 Outlook; Shares Up

Friedman Industries reported Q4 net income of $9.22 million, up from $5.35 million a year earlier, with EPS rising to $1.30 from $0.76. Net revenue increased to $191.78 million from $129.22 million, as sales volume rose to 0.19 million tons from 0.17 million. The company cited same-facility volume growth and expects Q1 FY27 volume comparable to the prior quarter and sequential margin improvement from higher average selling prices. Shares rose about 21% premarket to $32.02.

8/10
8/10
Med
Bullish
Pre-market today after Q4 results and Q1 FY27 outlook.
Shares up ~21% pre-market on the reported earnings and guidance.

Q4 beat driven by higher same-facility volume plus sequential Q1 margin improvement guidance supports near-term earnings expectations.

Friedman Industries reported Q4 net income of $9.22M vs $5.35M prior year and guided Q1 FY27 volume and margin improvement.

Bullish bias for the next session and into Q1 as traders price in higher margins and volume stability.

Background

Friedman Industries (FRD) is a steel manufacturing company reporting quarterly results and issuing a near-term volume/margin outlook.

Why it matters

The combination of higher Q4 profitability (net income, EPS, EBITDA) and a sequential Q1 FY27 margin improvement expectation is a direct catalyst for repricing the stock.

Market relevance

Traders can use the Q4 financials and Q1 FY27 guidance to update near-term earnings estimates and risk for FRD.

Market effects

A positive read-through for steel demand/pricing via same-facility volume growth and sequential margin improvement, though single-company impact is limited.

No specific regional demand signal beyond company-level volume and pricing commentary.

No direct global macro linkage beyond general steel pricing/margins.

Alternative perspectives

The guidance is framed as “comparable” volume with margin improvement tied to higher average selling prices—if pricing softens, the margin upside may fade.

The article doesn’t quantify cost inputs, backlog, or order book; traders may later focus on whether volume growth is sustainable or one-off.

Key entities

  • Friedman Industries, Inc.

    Reported Q4 profit growth and provided Q1 FY27 volume and sequential margin improvement outlook.

Related articles

$FRDMed

FRIEDMAN INDUSTRIES INC (FRD): Results of Operations and Financial Condition

FRIEDMAN INDUSTRIES INC (FRD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_975928.htm EXHIBIT 99.1 ex_975928.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2026 Results March 31, 2026 Quarter Highlights: ● Net earnings of $9.2 million; EBITDA of $15.2 million ● Sales of $191

$MSBMedAI 8/10

Mesoblast Shares Lead The ASX 200 Into The Weekend

Mesoblast (ASX: MSB) shares rose 6.67% to A$2.24 after the company reported fourth-quarter net revenue of US$36 million for the three months ended 30 June 2026, above market expectations. Full-year revenue was US$115 million, driven by stronger US uptake of its Ryoncil therapy in paediatric transplant patients.

$DALMed

Delta’s (NYSE:DAL) Q2 CY2026: Strong Sales

Delta Air Lines (NYSE: DAL) reported Q2 CY2026 revenue of $19.76 billion, up 18.7% year on year and 3.9% above Wall Street estimates, according to the company. GAAP EPS was $2.44, 64.7% above consensus. Operating margin was 9.4%. Analysts project full-year EPS to rise 25.3% to $7.54.

$PEPMed

Why Is PepsiCo Stock Falling Friday? - PepsiCo (NASDAQ:PEP)

PepsiCo (PEP) shares fell after its mixed Q2 results and earnings call. Revenue rose 6.4% to $24.18B, above the $23.96B estimate, but core EPS was $2.20, below $2.21. Management cited higher fuel costs pressuring discretionary spending, while reaffirming FY2026 guidance and expecting international strength.